2017 Value Watch List in US Oncology Market

Christina Corridon

2017 Value Watch List in US Oncology Market

> Download

As part of the ZS Oncology Value Watchdog Initiative, we have identified priority areas for manufacturers to consider as some of the most influential drivers of value-driven cancer care in the US in 2017. The movement from volume-driven to value-driven care couldn’t be more true than in the Oncology landscape. This movement continues to be incredibly dynamic and innovative. Over the next year we plan to track some specific prioritized areas on our “Value Watch List” and provide updates on implications based on market events and evolution.

About the Expert

Christina Corridon is a Manager in the Boston office and a leader in the ZS Oncology Practice. She has over a decade experience working in the pharmaceutical and biotech industries, with specific expertise in oncology and biosimilars. During her consulting career she has worked on US and global projects spanning commercialization strategy including launch strategy and planning, go-to market strategy, commercial models, marketing strategy and brand planning. Christina has an MPH in Health Policy and Management from the UCLA Fielding School of Public Health and an MBA from the Stern School of Business at New York University focused in Marketing. Christina completed her BA at Cornell University.                 

Contact ZS